Supplementary Figure. Proportion of Invasive Pneumococcal Disease Cases by Vaccine-Type and Vaccination Coverage Among Adults Aged 19–64 Years (a) and ≥65 Years (B) With an Indication for Pneumococcal Vaccination —United States 2018–2022

Details

• Alternative Title:
  Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024: Supplementary Figure. Proportion of Invasive Pneumococcal Disease Cases by Vaccine-Type and Vaccination Coverage Among Adults Aged 19–64 Years (a) and ≥65 Years (B) With an Indication for Pneumococcal Vaccination —United States 2018–2022
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Current Epidemiology of Pneumococcal Disease among Adults, United States
• Subjects:
  Immunization Programs / Organization & Administration Pneumococcal Infections / Epidemiology Pneumococcal Infections / Prevention & Control Streptococcus Pneumoniae / Immunology Vaccines / Administration & Dosage
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 36
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  2 pdf pages
• Volume:
  73
• Issue:
  36
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:801fa42bf3c9e9dd0ab270f6dff11cc4aba4c4679cd96d932b1385974a39e2e931df5c859c52992207acc0907cc432a96fe9c0bb034052c695f28d804b601587
• Download URL:
  https://stacks.cdc.gov/view/cdc/160379/cdc_160379_DS1.pdf
• File Type:
  [PDF - 219.66 KB ]